Clinical Trial Update: Lysyl Oxidase, Semaphorin 7a and Semaphorin 3a in Patients With Systemic Sclerosis [NA]

View source ↗

Summary

This entry reports a clinical trial evaluating lysyl oxidase and semaphorin 7a/3a in patients with systemic sclerosis. The current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: Hillel Yaffe Medical Center | Conditions: Systemic Sclerosis | NA | Status: UNKNOWN